Conformis Inc represents strong values and a clear corporate philosophy. As a leading medical technology company, Conformis focuses on providing customized orthopedic implants, designed to fit each patient's unique anatomy. Commitment to innovation, patient-centricity, and improving the quality of life drive Conformis' operations. By leveraging advanced imaging technology and proprietary software, the company aims to streamline the surgical process, enhance patient outcomes, and reduce healthcare costs. Conformis' unwavering dedication to personalized solutions and delivering exceptional patient experiences solidifies its position as a trusted leader in the orthopedic industry.

Conformis Inc is primarily present in the United States.

Conformis Inc, a leading medical technology company, has achieved several significant milestones. The company has successfully developed and commercialized innovative joint replacement implants and systems that are tailored to each patient's unique anatomy. Conformis Inc has received FDA clearance for its knee and hip replacement products, showcasing their commitment to safety and effectiveness. They have also gained regulatory approvals in various markets around the world, expanding their global presence. Additionally, Conformis Inc has secured partnerships and collaborations with renowned orthopedic organizations, enabling them to advance their research and development efforts. This dedication to innovation and strategic partnerships has positioned Conformis Inc as a leader in the orthopedic medical device industry.

Conformis Inc, founded in 2004, is a leading medical technology company that specializes in orthopedic implant design and manufacturing. The company is headquartered in Billerica, Massachusetts. Conformis Inc focuses on providing patient-specific and highly customized joint replacement solutions, particularly knee and hip implants. By utilizing advanced 3D printing technology and imaging software, Conformis Inc is able to create implants that are tailored to each patient's unique anatomy, resulting in potentially better outcomes and improved patient satisfaction. The company has a successful track record of innovation and is committed to addressing the individual needs of patients while ensuring the highest quality of care.

Conformis Inc faces competition from various players in the orthopedic implant market. Some of its main competitors include Zimmer Biomet Holdings Inc, Stryker Corporation, and Smith & Nephew plc. These companies also specialize in manufacturing and marketing orthopedic implants, including knee and hip replacements. Conformis Inc distinguishes itself by offering patient-specific implants and instrumentation, providing a personalized approach to orthopedic surgery. Despite competition, Conformis Inc has carved a niche for itself with its innovative solutions tailored to individual patients, enhancing the overall quality of care in the orthopedic industry.

Conformis Inc is primarily active in the medical devices industry.

The business model of Conformis Inc is focused on providing innovative and patient-specific solutions for orthopedic surgeons. The company develops and sells personalized joint replacement implants and associated surgical instruments. Through advanced imaging technology and proprietary software, Conformis Inc creates implants that are tailor-made for each patient, taking into account their unique anatomy. By offering this personalized approach, Conformis Inc aims to enhance patient outcomes, improve surgical efficiency, and reduce the need for secondary surgeries. This patient-specific solution sets Conformis Inc apart and positions the company as a leader in the field of orthopedic joint replacements.

Conformis의 P/E 비율은 -0.02입니다.

Conformis의 P/S 비율은 0.27입니다.

Conformis에 대한 AlleAktien 품질 점수는 3/10입니다.

예상되는 Conformis 매출은 60.12 백만 USD입니다.

예상되는 Conformis 이익은 -887.25 백만 USD입니다.

Conformis Inc. is a leading company in the field of medical technology that develops, manufactures, and sells specially customized orthopedic implants and instruments for use in knee, hip, and shoulder surgery. The company combines state-of-the-art technology with clinical insights to provide unique solutions for individual anatomical needs and surgical challenges. The business model is based on the production and sale of personalized implants and instruments, using computer-assisted imaging technologies and manufacturing processes to produce individualized implants and instruments in series. This allows for a precise fit and faster healing, leading to better outcomes for patients. The company is active in three main segments: knee, hip, and shoulder. In knee surgery, Conformis offers a portfolio of knee implants that are made according to the specific needs of the patient, including total, partial, cartilage, and ligament-replacing implants. In hip surgery, Conformis offers a customized acetabular cup that helps ensure a precise fit and more natural hip movements. The company also offers customized hip implants that meet the anatomical needs of the patient. In shoulder surgery, Conformis offers a wide range of individualized shoulder implants, including total and partial implants. The implants are particularly precise with regard to the rotator cuff, the size and shape of the joint head, as well as the acromion and glenoid. Conformis is also proud to offer instruments and accessories that allow surgeons to receive real-time interactive information about the patient's anatomy during the procedure. These include patient-specific templates and drill templates that accurately match the patient's anatomical requirements. Another important pillar of the business model is collaboration with clinicians and surgeons. Conformis works with renowned clinics and surgeons to constantly develop and improve new products. The company aims to reduce procedural errors and increase the efficiency of orthopedic surgery. Overall, the business model of Conformis Inc. is focused on providing personalized solutions in orthopedic surgery that help patients heal faster and better. The company focuses on product development, manufacturing, distribution, and collaboration with doctors and clinics to ensure that the patient's need for individualized solutions is optimally met. Conformis Inc. is an innovative company with a strong focus on improving patient care.

Conformis은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

Conformis의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Conformis의 ISIN은 US20717E1010입니다.

Conformis의 WKN은 A14T0Y입니다.

Conformis의 티커는 CFMS입니다.

지난 12개월 동안 Conformis은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Conformis은(는) 0 USD의 배당금을 지급할 것으로 예상됩니다.

Conformis의 현재 배당 수익률은 입니다.

Conformis은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Conformis은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

향후 12개월 동안 0 USD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Conformis은 '건강' 섹터에 속합니다.

Conformis의 마지막 배당금을 0 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

마지막 배당금 지급일은 입니다.

2023년에 Conformis는 0 USD를 배당금으로 지급했습니다.

Conformis의 배당금은 USD에 지급됩니다.